HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.

Abstract
Necroptosis is a form of programmed necrosis mediated by signaling complexes with receptor-interacting protein 1 (RIP1) and RIP3 kinases as the main mediators. However, the underlying execution pathways of this phenomenon have yet to be elucidated in detail. In this study, a RIP1/RIP3 complex was formed in 2-methoxy-6-acetyl-7-methyljuglone (MAM)-treated HCT116 and HT29 colon cancer cells. With this formation, mitochondrial reactive oxygen species (ROS) levels increased, mitochondrial depolarization occurred, and ATP concentrations decreased. This process was identified as necroptosis. This finding was confirmed by experiments showing that MAM-induced cell death was attenuated by the pharmacological or genetic blockage of necroptosis signaling, including RIP1 inhibitor necrostatin-1s (Nec-1s) and siRNA-mediated gene silencing of RIP1 and RIP3, but was unaffected by caspase inhibitor z-vad-fmk or necrosis inhibitor 2-(1H-Indol-3-yl)-3-pentylamino-maleimide (IM54). Transmission electron microscopy (TEM) analysis further revealed the ultrastructural features of MAM-induced necroptosis. MAM-induced RIP1/RIP3 complex triggered necroptosis through cytosolic calcium (Ca2+) accumulation and sustained c-Jun N-terminal kinase (JNK) activation. Both calcium chelator BAPTA-AM and JNK inhibitor SP600125 could attenuate necroptotic features, including mitochondrial ROS elevation, mitochondrial depolarization, and ATP depletion. 2-thenoyltrifluoroacetone (TTFA), which is a mitochondrial complex II inhibitor, was found to effectively reverse both MAM induced mitochondrial ROS generation and cell death, indicating the complex II was the ROS-producing site. The essential role of mitochondrial ROS was confirmed by the protective effect of overexpression of manganese superoxide dismutase (MnSOD). MAM-induced necroptosis was independent of TNFα, p53, MLKL, and lysosomal membrane permeabilization. In summary, our study demonstrated that RIP1/RIP3 complex-triggered cytosolic calcium accumulation is a critical mediator in MAM-induced necroptosis through sustained JNK activation and mitochondrial ROS production. Our study also provided new insights into the molecular regulation of necroptosis in human colon cancer cells.
AuthorsWen Sun, Xiaxia Wu, Hongwei Gao, Jie Yu, Wenwen Zhao, Jin-Jian Lu, Jinhua Wang, Guanhua Du, Xiuping Chen
JournalFree radical biology & medicine (Free Radic Biol Med) Vol. 108 Pg. 433-444 (07 2017) ISSN: 1873-4596 [Electronic] United States
PMID28414098 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2017 Elsevier Inc. All rights reserved.
Chemical References
  • AGFG1 protein, human
  • Imidazoles
  • Indoles
  • Multiprotein Complexes
  • Naphthoquinones
  • Nuclear Pore Complex Proteins
  • RNA, Small Interfering
  • RNA-Binding Proteins
  • Reactive Oxygen Species
  • necrostatin-1
  • RIPK3 protein, human
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • MAP Kinase Kinase 4
  • Calcium
Topics
  • Calcium (metabolism)
  • Cell Death
  • Colonic Neoplasms (metabolism)
  • Cytosol (metabolism)
  • HCT116 Cells
  • Humans
  • Imidazoles (pharmacology)
  • Indoles (pharmacology)
  • MAP Kinase Kinase 4 (metabolism)
  • Mitochondria (metabolism)
  • Multiprotein Complexes (metabolism)
  • Naphthoquinones (pharmacology)
  • Nuclear Pore Complex Proteins (antagonists & inhibitors, genetics, metabolism)
  • RNA, Small Interfering (genetics)
  • RNA-Binding Proteins (antagonists & inhibitors, genetics, metabolism)
  • Reactive Oxygen Species (metabolism)
  • Receptor-Interacting Protein Serine-Threonine Kinases (genetics, metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: